Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
6.28
+0.42 (7.17%)
Dec 20, 2024, 4:00 PM EST - Market closed
Enanta Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2015 |
| Net Income | -116.05 | -116.05 | -133.82 | -121.76 | -79 | -36.17 | Upgrade
|
| Depreciation & Amortization | 2.34 | 2.34 | 2.37 | 2.97 | 3.33 | 3.64 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.02 | 0.02 | 0.15 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.14 | -1.14 | -2.93 | 0.33 | -1.91 | -3.27 | Upgrade
|
| Stock-Based Compensation | 26.8 | 26.8 | 28.22 | 26.97 | 20.99 | 19.58 | Upgrade
|
| Other Operating Activities | 2.14 | 2.14 | -5.17 | -0.08 | 0.28 | 10.41 | Upgrade
|
| Change in Accounts Receivable | 1.97 | 1.97 | 11.7 | 3.26 | -0.08 | 27.82 | Upgrade
|
| Change in Accounts Payable | -0.41 | -0.41 | -1.15 | -4.63 | 3.77 | -0.88 | Upgrade
|
| Change in Income Taxes | -1 | -1 | -2.29 | 8.54 | -24.21 | -4.13 | Upgrade
|
| Change in Other Net Operating Assets | 6.57 | 6.57 | -0.24 | -0.37 | 6.84 | -9.91 | Upgrade
|
| Operating Cash Flow | -78.76 | -78.76 | -103.15 | -84.78 | -70 | 7.09 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | - | -90.08% | Upgrade
|
| Capital Expenditures | -17.95 | -17.95 | -9.06 | -2.13 | -0.75 | -1.45 | Upgrade
|
| Investment in Securities | 76.18 | 76.18 | -44.52 | 57.02 | 37.74 | 21.28 | Upgrade
|
| Investing Cash Flow | 58.24 | 58.24 | -53.58 | 54.9 | 36.99 | 19.83 | Upgrade
|
| Issuance of Common Stock | 0.15 | 0.15 | 2.21 | 21.26 | 3.61 | 10.48 | Upgrade
|
| Other Financing Activities | -27.77 | -27.77 | 195.92 | -1.23 | -0.53 | -1.5 | Upgrade
|
| Financing Cash Flow | -27.63 | -27.63 | 198.13 | 20.03 | 3.08 | 8.98 | Upgrade
|
| Net Cash Flow | -48.16 | -48.16 | 41.39 | -9.85 | -29.93 | 35.9 | Upgrade
|
| Free Cash Flow | -96.71 | -96.71 | -112.21 | -86.91 | -70.75 | 5.64 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | -91.45% | Upgrade
|
| Free Cash Flow Margin | -142.99% | -142.99% | -141.67% | -100.87% | -72.88% | 4.61% | Upgrade
|
| Free Cash Flow Per Share | -4.57 | -4.57 | -5.35 | -4.22 | -3.51 | 0.28 | Upgrade
|
| Cash Interest Paid | 11.71 | 11.71 | 1.99 | - | - | - | Upgrade
|
| Cash Income Tax Paid | 0.24 | 0.24 | 4.9 | - | 0.03 | 0.11 | Upgrade
|
| Levered Free Cash Flow | -71.38 | -71.38 | -62.34 | -42.08 | -57.67 | 9.55 | Upgrade
|
| Unlevered Free Cash Flow | -64.55 | -64.55 | -59.13 | -42.08 | -57.67 | 9.55 | Upgrade
|
| Change in Net Working Capital | -0.33 | -0.33 | -5.1 | -7.51 | 12.76 | -13.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.